Your browser doesn't support javascript.
loading
Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer.
Moloney, Kristen; Janda, Monika; Frumovitz, Michael; Leitao, Mario; Abu-Rustum, Nadeem R; Rossi, Emma; Nicklin, James L; Plante, Marie; Lecuru, Fabrice R; Buda, Alessandro; Mariani, Andrea; Leung, Yee; Ferguson, Sarah Elizabeth; Pareja, Rene; Kimmig, Rainer; Tong, Pearl Shuang Ye; McNally, Orla; Chetty, Naven; Liu, Kaijiang; Jaaback, Ken; Lau, Julio; Ng, Soon Yau Joseph; Falconer, Henrik; Persson, Jan; Land, Russell; Martinelli, Fabio; Garrett, Andrea; Altman, Alon; Pendlebury, Adam; Cibula, David; Altamirano, Roberto; Brennan, Donal; Ind, Thomas Edward; De Kroon, Cornelis; Tse, Ka Yu; Hanna, George; Obermair, Andreas.
Afiliação
  • Moloney K; Gynaecologic Oncology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
  • Janda M; Centre for Health Services Research, The University of Queensland Faculty of Medicine, Brisbane, Queensland, Australia.
  • Frumovitz M; Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Leitao M; Gynecology Service Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Abu-Rustum NR; Gynecology Service Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Rossi E; Obstetrics and Gynecology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Nicklin JL; Gynaecological Oncology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
  • Plante M; Faculty of Medicine, The University of Queensland, St Lucia, Queensland, Australia.
  • Lecuru FR; Gynecology Oncology Service, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, Quebec, Canada.
  • Buda A; Surgical Oncology, Institute Curie, Paris, France.
  • Mariani A; Surgical Oncology Department for Breast and Gynecology, Universite de Paris, Paris, Île-de-France, France.
  • Leung Y; Department of Obstetrics and Gynecology, Università degli Studi Milano-Bicocca, San Gerardo Hospital, Monza, Italy.
  • Ferguson SE; Division of Gynecologic Oncology Italy, Ospedale Michele e Pietro Ferrero, Verduno (CN), Italy.
  • Pareja R; Gynecologic Surgery, Department of Obstetrics and Gynecology, Mayo Clinic Rochester, Rochester, Minnesota, USA.
  • Kimmig R; Obstetrics and Gynaecology, The University of Western Australia Faculty of Health and Medical Sciences, Perth, Western Australia, Australia.
  • Tong PSY; Gynecologic Oncology, University Health Network, Toronto, Ontario, Canada.
  • McNally O; Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario, Canada.
  • Chetty N; Gynecologic Oncology, Instituto Nacional de Cancerologia, Bogota, Colombia.
  • Liu K; Gynecologic Oncology, Clínica De Oncología Astorga, Medellín, Colombia.
  • Jaaback K; Gynecology and Obstetrics, University of Essen, Essen, Germany.
  • Lau J; Gynaecologic Oncology, National University Health System, Singapore.
  • Ng SYJ; Obstetrics and Gynaecology, Royal Women's Hospital, Parkville, Victoria, Australia.
  • Falconer H; Victorian Comprehensive Cancer Centre, University of Melbourne, Parkville, Victoria, Australia.
  • Persson J; Gynaecologic Oncology, Mater Health Services Brisbane, South Brisbane, Queensland, Australia.
  • Land R; Gynecology and Obstetrics, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, China.
  • Martinelli F; Gynaecologic Oncology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
  • Garrett A; Gynecology Oncology, Hospital General San Juan de Dios, Guatemala, Guatemala.
  • Altman A; Gynecology Oncology, University of San Carlos de Guatemala Faculty of Medical Sciences, Guatemala, Guatemala.
  • Pendlebury A; Obstetrics and Gynaecology, National University of Singapore, Singapore.
  • Cibula D; Women's and Children's Health, Karolinska Institute, Stockholm, Sweden.
  • Altamirano R; Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.
  • Brennan D; Obstetrics and Gynaecology, Skanes Universitetssjukhus Lund, Lund, Skåne, Sweden.
  • Ind TE; Clinical Sciences, Obstetrics and Gynaecology, Lund University Faculty of Medicine, Lund, Sweden.
  • De Kroon C; Gynaecologic Oncology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
  • Tse KY; Faculty of Medicine, The University of Queensland, St Lucia, Queensland, Australia.
  • Hanna G; Gynaecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Obermair A; Gynaecologic Oncology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
Int J Gynecol Cancer ; 31(5): 647-655, 2021 05.
Article em En | MEDLINE | ID: mdl-33664126
ABSTRACT

INTRODUCTION:

Sentinel lymph node dissection is widely used in the staging of endometrial cancer. Variation in surgical techniques potentially impacts diagnostic accuracy and oncologic outcomes, and poses barriers to the comparison of outcomes across institutions or clinical trial sites. Standardization of surgical technique and surgical quality assessment tools are critical to the conduct of clinical trials. By identifying mandatory and prohibited steps of sentinel lymph node (SLN) dissection in endometrial cancer, the purpose of this study was to develop and validate a competency assessment tool for use in surgical quality assurance.

METHODS:

A Delphi methodology was applied, included 35 expert gynecological oncology surgeons from 16 countries. Interviews identified key steps and tasks which were rated mandatory, optional, or prohibited using questionnaires. Using the surgical steps for which consensus was achieved, a competency assessment tool was developed and subjected to assessments of validity and reliability.

RESULTS:

Seventy percent consensus agreement standardized the specific mandatory, optional, and prohibited steps of SLN dissection for endometrial cancer and informed the development of a competency assessment tool. Consensus agreement identified 21 mandatory and three prohibited steps to complete a SLN dissection. The competency assessment tool was used to rate surgical quality in three preselected videos, demonstrating clear separation in the rating of the skill level displayed with mean skills summary scores differing significantly between the three videos (F score=89.4; P<0.001). Internal consistency of the items was high (Cronbach α=0.88).

CONCLUSION:

Specific mandatory and prohibited steps of SLN dissection in endometrial cancer have been identified and validated based on consensus among a large number of international experts. A competency assessment tool is now available and can be used for surgeon selection in clinical trials and for ongoing, prospective quality assurance in routine clinical care.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Biópsia de Linfonodo Sentinela / Ginecologia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Biópsia de Linfonodo Sentinela / Ginecologia Idioma: En Ano de publicação: 2021 Tipo de documento: Article